In this context, purinergic signaling pathways, primarily mediated by the up-regulation and activation of the P2X7 receptor induced by increased extracellular ATP accumulation, have been identified as key mediators of multiple aspects of cancer progression [52,53]. This evidence concerns the gene P2RX7 and cancer.